Ledger.Open graph →
SEC Form D · filed March 30, 2011

SYNAGEVA BIOPHARMA CORP

Offering
$25.0M
Sold
$12.5M
Exemption
—
Industry
Biotechnology
Location
LEXINGTON, MA
Type
—

People & firms on this filing (12)

Felix J. Baker · LEXINGTON, MADirectorMark Goldberg · LEXINGTON, MADirectorStephen R. Biggar · LEXINGTON, MADirectorJames L. Tullis · Stamford, CTDirectorSanj K. Patel · LEXINGTON, MAExec · DirectorThomas R. Malley · LEXINGTON, MADirectorFelix J. Baker · Mountain View, CADirectorSrini Akkaraju · Waltham, MADirectorMark Goldberg · SAN FRANCISCO, CADirectorStephen R. Biggar · Vancouver, British Columbia, CanadaDirectorRobyn Samuels · LEXINGTON, MADirectorJames L. Tullis · Palm Beach Gardens, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗